Log In
person
Puma Biotechnology Inc
PBYI
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Oncology Pharma |
Branded Pharmaceuticals (outsourced)
These companies research, develop, and outsource the manufacturing of patented drugs.
|
203.11M | 86.19% |
| Oncology Pharma |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
32.53M | 13.81% |
| keyboard_arrow_down |
Oncology Pharma
Branded Pharmaceuticals (outsourced)
|
203.11M | 86.19% |
| keyboard_arrow_right |
These companies research, develop, and outsource the manufacturing of patented drugs.
|
||
| keyboard_arrow_down |
Oncology Pharma
Pharmaceutical Patent Licensing
|
32.53M | 13.81% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||